Skip to main content
Erschienen in: World Journal of Urology 9/2023

14.07.2023 | Original Article

Outcomes of thulium prostatectomy with “Oyster technique” versus transurethral prostatectomy (TURP): a randomized control trial

verfasst von: Dimitrios Kotsiris, Vasileios Tatanis, Angelis Peteinaris, Vasileios Tzenetidis, Konstantinos Pagonis, Panteleimon Ntasiotis, Constantinos Adamou, Theofanis Vrettos, Evangelos Liatsikos, Panagiotis Kallidonis

Erschienen in: World Journal of Urology | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the perioperative and postoperative outcomes between Oyster prostate vaporesection using Tm−YAG laser and the conventional transurethral prostatectomy using monopolar energy.

Methods

Patients with LUTS with an accumulative size of at least 60 ml were randomly assigned to one of two parallel groups to undergo Tm-YAG laser vaporesection (Group 1) or conventional monopolar transurethral prostatectomy (Group 2). The primary endpoints were the reduction in IPSS and the increase in Qmax postoperatively. Secondary endpoints included the Hemoglobin drop, the complication rate, the changes in urodynamic parameters, the duration of hospitalization and catheterization and the changes in IIEF during the 24-month follow-up.

Results

In total 32 and 30 patients were enrolled in Groups 1 and 2, respectively. Patient age (p = 0.422) and prostate volume were similar among the groups (p = 0.51). The outcomes in terms of IPSS decrease and Qmax amelioration were comparable (p = 0.449 and p = 0.237, respectively). Operative and hospitalization times were lower in Group 1 (p = 0.002 and p = 0.004, respectively). Hemoglobin drop, changes in urodynamic parameters and improvement in IIEF and QoL scores did not differ among the two Groups. The average time with the catheter was 2.06 ± 0.35 and 2.5 ± 0.82 (p = 0.003) days for Group 1 and Group 2, respectively. The overall complication rate was 6.2% for Group 1 and 13.3% for Group 2.

Conclusions

The Oyster technique leads to similar postoperative outcomes compared to the standard monopolar transurethral prostatectomy. The shorter catheterization, hospitalization and operation time should be considered advantages of the Oyster technique.
Literatur
1.
Zurück zum Zitat Robert G, De La Taille A, Descazeaud A (2018) Epidemiology of benign prostatic hyperplasia. Progres Urol: J Assoc Fr Urol Soc Fr Urol 28(15):803–812CrossRef Robert G, De La Taille A, Descazeaud A (2018) Epidemiology of benign prostatic hyperplasia. Progres Urol: J Assoc Fr Urol Soc Fr Urol 28(15):803–812CrossRef
3.
Zurück zum Zitat Gravas S, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C, Rieken M, Speakman MJ, Tikkinen KAO (2020) EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. Benign prostatic obstruction (BPO). EAU guidelines, pp 34–5 Gravas S, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C, Rieken M, Speakman MJ, Tikkinen KAO (2020) EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. Benign prostatic obstruction (BPO). EAU guidelines, pp 34–5
4.
Zurück zum Zitat Ho HS, Yip SK, Lim KB, Fook S, Foo KT, Cheng CW (2007) A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol 52(2):517–522CrossRefPubMed Ho HS, Yip SK, Lim KB, Fook S, Foo KT, Cheng CW (2007) A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol 52(2):517–522CrossRefPubMed
5.
Zurück zum Zitat Bach T, Muschter R, Sroka R, Gravas S, Skolarikos A, Herrmann TR et al (2012) Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol 61(2):317–325CrossRefPubMed Bach T, Muschter R, Sroka R, Gravas S, Skolarikos A, Herrmann TR et al (2012) Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol 61(2):317–325CrossRefPubMed
6.
Zurück zum Zitat Deininger S, Herrmann T, Schönburg S, Törzsök P, Kunit T, Lusuardi L (2020) Surgical treatment of benign prostatic obstruction (BPO) in patients under anticoagulation: a review of the bleeding risks of established techniques. Der Urologe Ausg A 59(10):1187–1194CrossRefPubMedPubMedCentral Deininger S, Herrmann T, Schönburg S, Törzsök P, Kunit T, Lusuardi L (2020) Surgical treatment of benign prostatic obstruction (BPO) in patients under anticoagulation: a review of the bleeding risks of established techniques. Der Urologe Ausg A 59(10):1187–1194CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Bach T, Wendt-Nordahl G, Michel MS, Herrmann TR, Gross AJ (2009) Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 27(4):541–545CrossRefPubMed Bach T, Wendt-Nordahl G, Michel MS, Herrmann TR, Gross AJ (2009) Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 27(4):541–545CrossRefPubMed
8.
Zurück zum Zitat Bach T, Netsch C, Pohlmann L, Herrmann TR, Gross AJ (2011) Thulium:YAG vapoenucleation in large volume prostates. J Urol 186(6):2323–2327CrossRefPubMed Bach T, Netsch C, Pohlmann L, Herrmann TR, Gross AJ (2011) Thulium:YAG vapoenucleation in large volume prostates. J Urol 186(6):2323–2327CrossRefPubMed
9.
Zurück zum Zitat Becker B, Orywal AK, Gross AJ, Netsch C (2019) Thulium vapoenucleation of the prostate (ThuVEP) for prostates larger than 85 ml: long-term durability of the procedure. Lasers Med Sci 34(8):1637–1643CrossRefPubMed Becker B, Orywal AK, Gross AJ, Netsch C (2019) Thulium vapoenucleation of the prostate (ThuVEP) for prostates larger than 85 ml: long-term durability of the procedure. Lasers Med Sci 34(8):1637–1643CrossRefPubMed
10.
Zurück zum Zitat Netsch C, Magno C, Butticè S, Macchione L, Mucciardi G, Herrmann TR et al (2016) Thulium Vaporesection of the prostate and thulium vapoenucleation of the prostate in patients on oral anticoagulants: a retrospective three-centre matched-paired comparison. Urol Int 96(4):421–426CrossRefPubMed Netsch C, Magno C, Butticè S, Macchione L, Mucciardi G, Herrmann TR et al (2016) Thulium Vaporesection of the prostate and thulium vapoenucleation of the prostate in patients on oral anticoagulants: a retrospective three-centre matched-paired comparison. Urol Int 96(4):421–426CrossRefPubMed
11.
Zurück zum Zitat Sener TE, Butticè S, Macchione L, Netsch C, Tanidir Y, Dragos L et al (2017) Thulium laser vaporesection of the prostate: Can we operate without interrupting oral antiplatelet/anticoagulant therapy? Investig Clin Urol 58(3):192–199CrossRefPubMedPubMedCentral Sener TE, Butticè S, Macchione L, Netsch C, Tanidir Y, Dragos L et al (2017) Thulium laser vaporesection of the prostate: Can we operate without interrupting oral antiplatelet/anticoagulant therapy? Investig Clin Urol 58(3):192–199CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Carmignani L, Macchi A, Ratti D, Finkelberg E, Casellato S, Maruccia S et al (2015) One day surgery in the treatment of benign prostatic enlargement with thulium laser: a single institution experience. Korean J Urol 56(5):365–369CrossRefPubMedPubMedCentral Carmignani L, Macchi A, Ratti D, Finkelberg E, Casellato S, Maruccia S et al (2015) One day surgery in the treatment of benign prostatic enlargement with thulium laser: a single institution experience. Korean J Urol 56(5):365–369CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Bozzini G, Seveso M, Melegari S, de Francesco O, Buffi NM, Guazzoni G et al (2017) Thulium laser enucleation (ThuLEP) versus transurethral resection of the prostate in saline (TURis): a randomized prospective trial to compare intra and early postoperative outcomes. Actas Urol Esp 41(5):309–315CrossRefPubMed Bozzini G, Seveso M, Melegari S, de Francesco O, Buffi NM, Guazzoni G et al (2017) Thulium laser enucleation (ThuLEP) versus transurethral resection of the prostate in saline (TURis): a randomized prospective trial to compare intra and early postoperative outcomes. Actas Urol Esp 41(5):309–315CrossRefPubMed
15.
Zurück zum Zitat Peng B, Wang GC, Zheng JH, Xia SQ, Geng J, Che JP et al (2013) A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia. BJU Int 111(4):633–637CrossRefPubMed Peng B, Wang GC, Zheng JH, Xia SQ, Geng J, Che JP et al (2013) A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia. BJU Int 111(4):633–637CrossRefPubMed
16.
Zurück zum Zitat Cui D, Sun F, Zhuo J, Sun X, Han B, Zhao F et al (2014) A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results. World J Urol 32(3):683–689CrossRefPubMed Cui D, Sun F, Zhuo J, Sun X, Han B, Zhao F et al (2014) A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results. World J Urol 32(3):683–689CrossRefPubMed
17.
Zurück zum Zitat Castellani D, Di Rosa M (2020) Thulium laser vapoenucleation of the prostate (ThuVEP) in men at high cardiovascular risk and on antithrombotic therapy: a single-center experience. J Clin Med 9(4):917CrossRefPubMedPubMedCentral Castellani D, Di Rosa M (2020) Thulium laser vapoenucleation of the prostate (ThuVEP) in men at high cardiovascular risk and on antithrombotic therapy: a single-center experience. J Clin Med 9(4):917CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389CrossRefPubMed Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389CrossRefPubMed
19.
Zurück zum Zitat Vargas C, Garcia-Larrosa A, Capdevila S, Laborda A (2014) Vaporization of the prostate with 150-w thulium laser: complications with 6-month follow-up. J Endourol 28(7):841–845CrossRefPubMedPubMedCentral Vargas C, Garcia-Larrosa A, Capdevila S, Laborda A (2014) Vaporization of the prostate with 150-w thulium laser: complications with 6-month follow-up. J Endourol 28(7):841–845CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Feng L, Zhang D, Tian Y, Song J (2016) Thulium laser enucleation versus plasmakinetic enucleation of the prostate: a randomized trial of a single center. J Endourol 30(6):665–670CrossRefPubMed Feng L, Zhang D, Tian Y, Song J (2016) Thulium laser enucleation versus plasmakinetic enucleation of the prostate: a randomized trial of a single center. J Endourol 30(6):665–670CrossRefPubMed
21.
Zurück zum Zitat Yang Z, Liu T, Wang X (2016) Comparison of thulium laser enucleation and plasmakinetic resection of the prostate in a randomized prospective trial with 5-year follow-up. Lasers Med Sci 31(9):1797–1802CrossRefPubMed Yang Z, Liu T, Wang X (2016) Comparison of thulium laser enucleation and plasmakinetic resection of the prostate in a randomized prospective trial with 5-year follow-up. Lasers Med Sci 31(9):1797–1802CrossRefPubMed
22.
Zurück zum Zitat Enikeev D, Glybochko P, Rapoport L, Okhunov Z, O’Leary M, Potoldykova N et al (2018) Impact of endoscopic enucleation of the prostate with thulium fiber laser on the erectile function. BMC Urol 18(1):87CrossRefPubMedPubMedCentral Enikeev D, Glybochko P, Rapoport L, Okhunov Z, O’Leary M, Potoldykova N et al (2018) Impact of endoscopic enucleation of the prostate with thulium fiber laser on the erectile function. BMC Urol 18(1):87CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Tiburtius C, Knipper S, Gross AJ, Netsch C (2014) Impact of thulium vapoenucleation of the prostate on erectile function: a prospective analysis of 72 patients at 12-month follow-up. Urology 83(1):175–180CrossRefPubMed Tiburtius C, Knipper S, Gross AJ, Netsch C (2014) Impact of thulium vapoenucleation of the prostate on erectile function: a prospective analysis of 72 patients at 12-month follow-up. Urology 83(1):175–180CrossRefPubMed
24.
Zurück zum Zitat Morozov A, Taratkin M, Kozlov V, Tarasov A, Bezrukov E, Enikeev M et al (2020) Retrospective assessment of endoscopic enucleation of prostate complications: a single-center experience of more than 1400 patients. J Endourol 34(2):192–197CrossRefPubMed Morozov A, Taratkin M, Kozlov V, Tarasov A, Bezrukov E, Enikeev M et al (2020) Retrospective assessment of endoscopic enucleation of prostate complications: a single-center experience of more than 1400 patients. J Endourol 34(2):192–197CrossRefPubMed
25.
Zurück zum Zitat Rijo E, Misrai V, Aho T, Gomez-Sancha F (2018) Recommendations for safe and efficient morcellation after endoscopic enucleation of the prostate. Urology 121:197CrossRefPubMed Rijo E, Misrai V, Aho T, Gomez-Sancha F (2018) Recommendations for safe and efficient morcellation after endoscopic enucleation of the prostate. Urology 121:197CrossRefPubMed
Metadaten
Titel
Outcomes of thulium prostatectomy with “Oyster technique” versus transurethral prostatectomy (TURP): a randomized control trial
verfasst von
Dimitrios Kotsiris
Vasileios Tatanis
Angelis Peteinaris
Vasileios Tzenetidis
Konstantinos Pagonis
Panteleimon Ntasiotis
Constantinos Adamou
Theofanis Vrettos
Evangelos Liatsikos
Panagiotis Kallidonis
Publikationsdatum
14.07.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 9/2023
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-023-04510-z

Weitere Artikel der Ausgabe 9/2023

World Journal of Urology 9/2023 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.